Nonketotic hyperglycinemia – Genetics Home Reference

Aliefendioğlu D, Tana Aslan Ay, Coşkun T, Dursun A, Cakmak FN, Kesimer M. Transient nonketotic

  • Aliefendioğlu D, Tana Aslan Ay, Coşkun T, Dursun A, Cakmak FN, Kesimer M. Transient nonketotic hyperglycinemia: two situation studies and literature evaluation. Pediatr Neurol. 2003 Feb28(two):151-five. Review.

  • Applegarth DA, Toone JR. Glycine encephalopathy (nonketotic hyperglycinaemia) : evaluation and update. J Inherit Metab Dis. 200427(three):417-22. Review.

  • Applegarth DA, Toone JR. Glycine encephalopathy (nonketotic hyperglycinemia): opinions and speculations. Am J Med Genet A. 2006 Jan 15140(two):186-8.

  • Coughlin CR 2nd, Swanson MA, Kronquist K, Acquaviva C, Hutchin T, Rodríguez-Pombo P, Väisänen ML, Spector E, Creadon-Swindell G, Brás-Goldberg AM, Rahikkala E, Moilanen JS, Mahieu V, Matthijs G, Bravo-Alonso I, Pérez-Cerdá C, Ugarte M, Vianey-Saban C, Scharer GH, Van Hove JL. The genetic foundation of typical nonketotic hyperglycinemia owing to mutations in GLDC and AMT. Genet Med. 2017 Jan19(one):104-111. doi: ten.1038/gim.2016.seventy four. Epub 2016 Jun 30. Erratum in: Genet Med. 2018 Jan 04:.

  • Dinopoulos A, Matsubara Y, Kure S. Atypical variants of nonketotic hyperglycinemia. Mol Genet Metab. 2005 Sep-Oct86(one-two):61-9. Review.

  • Hoover-Fong JE, Shah S, Van Hove JL, Applegarth D, Toone J, Hamosh A. Pure heritage of nonketotic hyperglycinemia in 65 sufferers. Neurology. 2004 Nov 2363(ten):1847-53.

  • Kikuchi G, Motokawa Y, Yoshida T, Hiraga K. Glycine cleavage process: response mechanism, physiological significance, and hyperglycinemia. Proc Jpn Acad Ser B Phys Biol Sci. 200884(seven):246-63. Review.

  • Stence NV, Fenton LZ, Levek C, Tong S, Coughlin CR 2nd, Hennermann JB, Wortmann SB, Van Hove JLK. Mind imaging in typical nonketotic hyperglycinemia: Quantitative investigation and relation to phenotype. J Inherit Metab Dis. 2019 May42(three):438-450. doi: ten.1002/jimd.12072. Epub 2019 Mar 20.

  • Swanson MA, Coughlin CR Jr, Scharer GH, Szerlong HJ, Bjoraker KJ, Spector EB, Creadon-Swindell G, Mahieu V, Matthijs G, Hennermann JB, Applegarth DA, Toone JR, Tong S, Williams K, Van Hove JL. Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. Ann Neurol. 2015 Oct78(four):606-eighteen. doi: ten.1002/ana.24485. Epub 2015 Aug ten. Erratum in: Ann Neurol. 2016 Mar79(three):505.

  • Van Hove J, Coughlin C II, Scharer G. Glycine Encephalopathy. 2002 Nov 14 [up-to-date 2013 Jul 11]. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Fowl TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Net]. Seattle (WA): University of Washington, Seattle 1993-2017. Readily available from http://www.ncbi.nlm.nih.gov/textbooks/NBK1357/